Transcode Therapeutics, Inc. (RNAZ) Insider Trading

Name: Transcode Therapeutics, Inc. (RNAZ) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 11, 2026): Fitzgerald Thomas A (Chief Financial Officer): Grant/Award of 185,000 shares.

Get alerted when insiders trade RNAZ

Email address

Loading company data...

Beta

Loading company details...

Beta